BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1
38 results:

  • 1. Differential Regulation of Circadian Clock Genes by UV-B Radiation and 1,25-Dihydroxyvitamin D: A Pilot Study during Different Stages of Skin Photocarcinogenesis.
    Lamnis L; Christofi C; Stark A; Palm H; Roemer K; Vogt T; Reichrath J
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257148
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Monoallelic
    Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
    Front Immunol; 2022; 13():867443. PubMed ID: 35401501
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hemangioblastoma of the Peripheral Nervous System: A Critical Analysis of Its Rarity in Von Hippel-Lindau Disease.
    Murthy NK; Lonser RR; Spinner RJ
    World Neurosurg; 2021 Oct; 154():e707-e709. PubMed ID: 34343683
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DeepHPV: a deep learning model to predict human papillomavirus integration sites.
    Tian R; Zhou P; Li M; Tan J; Cui Z; Xu W; Wei J; Zhu J; Jin Z; Cao C; Fan W; Xie W; Huang Z; Xie H; You Z; Niu G; Wu C; Guo X; Weng X; Tian X; Yu F; Yu Z; Liang J; Hu Z
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33059369
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas.
    Ozkaya HM; Sahin S; Korkmaz OP; Durcan E; Sahin HR; Celik E; Poyraz BC; Kadioglu P
    Growth Horm IGF Res; 2020 Dec; 55():101356. PubMed ID: 33010581
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
    Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M
    J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multimodal pathway for brain tumor-related epilepsy patients: Observational study.
    Maialetti A; Maschio M; Zarabla A; Polimadei C; Papa E; Villani V; Giannarelli D
    Acta Neurol Scand; 2020 Jun; 141(6):450-462. PubMed ID: 32043558
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
    BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.
    Cao S; Zheng J; Liu X; Liu Y; Ruan X; Ma J; Liu L; Wang D; Yang C; Cai H; Li Z; Feng Z; Xue Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):37. PubMed ID: 30691465
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Eradication of Central Nervous System Leukemia of T-Cell Origin with a brain-Permeable LSD1 Inhibitor.
    Saito S; Kikuchi J; Koyama D; Sato S; Koyama H; Osada N; Kuroda Y; Akahane K; Inukai T; Umehara T; Furukawa Y
    Clin Cancer Res; 2019 Mar; 25(5):1601-1611. PubMed ID: 30518632
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impulse control disorders in patients with prolactinoma receiving dopamine agonist therapy: a prospective study with 1 year follow-up.
    Celik E; Ozkaya HM; Poyraz BC; Saglam T; Kadioglu P
    Endocrine; 2018 Dec; 62(3):692-700. PubMed ID: 30206771
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the brain and Fatal Neuroinflammation.
    Kim SS; Rait A; Garrido-Sanabria ER; Pirollo KF; Harford JB; Chang EH
    Mol Ther; 2018 Jan; 26(1):84-94. PubMed ID: 29103910
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks.
    Kalender Atak Z; Imrichova H; Svetlichnyy D; Hulselmans G; Christiaens V; Reumers J; Ceulemans H; Aerts S
    Genome Med; 2017 Aug; 9(1):80. PubMed ID: 28854983
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
    Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
    Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma.
    Ma D; Wang Y; Du G; Yang J; Tang Q; Zhou L
    Tumour Biol; 2016 Mar; 37(3):3765-74. PubMed ID: 26468019
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Depression and distress in caregivers of children with brain tumors undergoing treatment: psychosocial factors as moderators.
    Choi EK; Yoon SJ; Kim JH; Park HJ; Kim JY; Yu ES
    Psychooncology; 2016 May; 25(5):544-50. PubMed ID: 26426911
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Screening for cognitive deficits in 8 to 14-year old children with cerebellar tumors using self-report measures of executive and behavioral functioning and health-related quality of life.
    Bull KS; Liossi C; Peacock JL; Yuen HM; Kennedy CR;
    Neuro Oncol; 2015 Dec; 17(12):1628-36. PubMed ID: 26203065
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.
    Kim SS; Rait A; Kim E; Pirollo KF; Nishida M; Farkas N; Dagata JA; Chang EH
    ACS Nano; 2014 Jun; 8(6):5494-514. PubMed ID: 24811110
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.
    Kim SS; Rait A; Rubab F; Rao AK; Kiritsy MC; Pirollo KF; Wang S; Weiner LM; Chang EH
    Mol Ther; 2014 Feb; 22(2):278-291. PubMed ID: 24113515
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.